Article Details
Retrieved on: 2022-05-17 18:35:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Bluebird bio (BLUE) stock ~6% rose May 17 amid Morgan Stanley lowering its price target on the gene therapy developer's shares to $3 from $5.
Article found on: seekingalpha.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here